Live Q&A | Friday 19th September at 12.00pm (BST)/1.00pm (CEST)
After a short summer break, Petauri Evidence are back with the next instalment in our NHS Whispers series: live Q&A sessions with senior NHS decision-makers and industry experts, designed to help you make sense of the shifting NHS landscape in England.
Join us live as Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) leads the discussion with:
Together, they’ll explore the implications of changing NHS structure and policy, and what this means for your market access, stakeholder engagement, and product innovation strategies.
In previous sessions, we tackled NHS England restructuring, commissioning reshaping, and the future of integrated care boards (ICBs). Since then, several key developments have emerged:
This session is shaped by your questions. You can submit a question when you register, or ask it live during the webinar.
To help spark ideas, here are some of the themes we expect to touch on:
Expect a candid, interactive conversation – grounded in policy, informed by practice, and driven by what matters most to you.
Please do register, even if you can’t attend on the day, as all registrants will receive the recording after the event.
The webinar is free and open to all market access, patient access, field-based, and other healthcare professional‑facing teams in Pharmaceutical and Medtech companies. Some colleagues from other organisations may attend at the discretion of Petauri Evidence.
Sarah Everest Ford (Programme Director, Health and Care Partnership)
Sarah is a highly experienced senior healthcare leader and nurse, with a background in strategy, commissioning, project and programme management, operational management, and, of course, nursing. She has worked across the health and care sector for over 25 years, where she has held roles such as Strategy Director at OneMedical Group, Head of Business Development and Strategy at DHU Healthcare, Assistant Chief Commissioning Officer – Integration at North Derbyshire Clinical Commissioning Group (CCG), and Senior Public Health and Commissioning Manager at Nottinghamshire County Council.
Sarah recently authored this insights article ‘Navigating NHS Market Access: Policy Change and Opportunity in England’ for us, where she explored the transformation in the NHS and what this means for industry–NHS engagements. She also suggested actionable takeaways for Pharma and Medtech teams looking to achieve market access in the UK.
Patrick McGee (Deputy Programme Director for Pathology, Lancashire & South Cumbria)
Patrick was previously a key figure in the largest integrated care system in the country, serving as Head of Strategy, Planning, and Performance at the trailblazing NHS Greater Manchester Integrated Care Partnership.
In February 2024, he commenced a new role in the NHS as Deputy Programme Director for Pathology in Lancashire and South Cumbria, leading on a major transformation agenda.
Having first joined the NHS as a graduate management trainee, Patrick has led Women and Children’s services (including Elective, Cancer, Paediatric, and Maternity services) as an Operational Manager, and held roles as Senior Commissioner for Urgent and Emergency Care, and Primary and Community Care. During the COVID-19 pandemic, he was seconded as a Senior Policy Adviser to the Minister for Health at the Department for Health and Social Care.
Share